share_log

Artelo Biosciences Earlier Reported Q4 EPS $(0.99) Misses $(0.56) Estimate

Moomoo 24/7 ·  Mar 25 16:29

Artelo Biosciences (NASDAQ:ARTL) reported quarterly losses of $(0.99) per share which missed the analyst consensus estimate of $(0.56) by 76.79 percent. This is a 16.1 percent increase over losses of $(1.18) per share from the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment